Randomized trial of vitamin B12 in pregnant Indian women

印度孕妇维生素 B12 的随机试验

• 批准号: 7231556
• 负责人: CHRISTOPHER P DUGGAN
• 金额: $ 8.89万
• 依托单位: HARVARD SCHOOL OF PUBLIC HEALTH
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-06-01 至 2009-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7231556
• 关键词: Africa; Anemia; Ascorbic Acid; Asia; Birth; Birth Rate; Boston; Cardiovascular Diseases; Caring; Child; Child Nutrition; Chronic Disease; Clinical Trials; Cognitive; Cohort Studies; Commit; Country; Daily; Developed Countries; Developing Countries; Development; Developmental Disabilities; Diarrhea; Discipline of obstetrics; Double-Blind Method; Education; Effectiveness; Epidemiology; Evaluation; Fetal Growth; Fetal Growth Retardation; Folate; Gestational Age; Growth; HIV Seropositivity; Health; Health Expenditures; Hemoglobin; Homocysteine; Homocystine; Hospitalization; Incidence; India; Infant; Infant Mortality; Infection; Iron; Latin America; Learning; Low Birth Weight Infant; Maternal Age; Maternal and Child Health; Medical; Methylmalonic Acid; Micronutrients; Mothers; Nutritional status; Oral Administration; Outcome; Patient currently pregnant; Perinatal; Placebos; Pneumonia; Pre-Eclampsia; Pregnancy; Premature Birth; Premature Infant; Prematurity of fetus; Prenatal care; Public Health Schools; Randomized; Randomized Controlled Clinical Trials; Rate; Research Institute; Risk; Risk Factors; Role; Serum; Standards of Weights and Measures; Supplementation; Vitamin B 12; Vitamin B Complex; Week; Weight; Weight Gain; Woman; Work; cigarette smoking; design; fetal; improved; infant outcome; literate; maternal serum; nutrition; parity; prenatal; prospective; reproductive; size

DESCRIPTION (provided by applicant): The incidence of poor fetal growth and adverse maternal and infant birth outcomes is quite high in India, and several lines of evidence suggest that maternal nutritional status may be an important factor. We have previously performed extensive evaluations of poor fetal and infant outcomes in other settings, and found that maternal micronutrient supplementation (B vitamins including vitamin B12, plus vitamins C and E) in HIV positive Tanzanian mothers decreased the risk of low birthweight (<2500 g) by 44% (RR (95% Cl) 0.56 (0.38-0.82)), severe preterm birth (<34 weeks of gestation) by 39% (RR 0.61 (0.38-0.96)), and small size for gestational age at birth by 43% (RR 0.57 (0.39-0.82)). In a prospective cohort study of 410 pregnant Indian women, we recently found a strong relationship between maternal serum vitamin B12 concentration and risk of infant intrauterine growth retardation (IUGR). Compared to women in the highest tertile of serum B12 concentration, women in the lowest tertile were significantly more likely to have IUGR infants, after controlling for maternal age, weight, education, and parity (OR (95% Cl) 5.98 (1.72-20.74)). We now propose a randomized, double-blind trial among 300 pregnant Indian women in order to determine the effectiveness of vitamin B12 supplementation (50 ug daily) in improving maternal B12 status. Secondary aims for this exploratory trial include maternal hemoglobin, maternal weight gain during pregnancy and infant birthweight. All women will receive standard of prenatal obstetric care, including routine supplementation with iron and folate. The study will be a collaborative effort between the Division of Nutrition, St John's Research Institute, Bangalore, India, and the Department of Nutrition, Harvard School of Public Health, Boston, US. Findings from this planned study will be used to design and carry out a larger, more definitive clinical trial, as we have successfully performed elsewhere. As experts in the fields of nutrition, pediatrics, epidemiology and maternal and child health, our team is committed to further evaluating the possible role of micronutrients in improving maternal and child health outcomes in India.

描述(由申请人提供)：在印度，胎儿发育不良和母婴结局不良的发生率相当高，多条证据表明，孕妇的营养状况可能是一个重要因素。我们之前已经在其他环境下对不良的胎儿和婴儿结局进行了广泛的评估，发现在HIV阳性的坦桑尼亚母亲中，母亲补充微量营养素(包括维生素B12，加上维生素C和E)降低了44%(RR(95%CI)0.56(0.38-0.82))低出生体重(&lt；2500克)的风险，严重早产(&lt；孕34周)减少39%(RR 0.61(0.38-0.96))，出生时小号胎龄减少43%(RR 0.57(0.39-0.82))。在一项对410名印度孕妇进行的前瞻性队列研究中，我们最近发现，孕妇血清维生素B12浓度与婴儿宫内发育迟缓(IUGR)的风险密切相关。在控制了孕妇的年龄、体重、教育程度和产次后，与血清B12浓度最高的三分位数的妇女相比，最低三分位数的妇女更有可能生下IUGR婴儿(OR(95%CI)5.98(1.72-20.74))。我们现在建议在300名印度孕妇中进行随机双盲试验，以确定补充维生素B12(每天50微克)在改善母亲B12状况方面的有效性。这项探索性试验的次要目标包括母体血红蛋白、母体孕期体重增加和婴儿出生体重。所有妇女都将得到标准的产前护理，包括常规的铁和叶酸补充。这项研究将由印度班加罗尔圣约翰研究所营养学部和美国波士顿哈佛公共卫生学院营养学系合作完成。这项计划中的研究结果将用于设计和进行更大规模、更明确的临床试验，就像我们在其他地方成功进行的那样。作为营养、儿科、流行病学和妇幼健康领域的专家，我们的团队致力于进一步评估微量营养素在改善印度妇幼健康成果方面可能发挥的作用。